Prova cardiopolmonare in pazienti adulti con cardiopatia congenita.

Translated title of the contribution: [Cardiopulmonary exercise test in adults with congenital heart disease].

D. Negura, A. Micheletti, M. Chessa, R. Calaciura, A. Saracino, G. Butera, L. Piazza, C. Arcidiacono, M. Carminati

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Cardiopulmonary exercise testing (CPET) gives important information about functional capacity by direct measurement of exercise respiratory gas exchange. It provides assessment of the integrative exercise responses involving the cardiovascular, respiratory and muscle-skeletal systems which are not adequately investigated through the measurement of individual organ system function. CPET involves measurements of oxygen uptake (VO2), carbon dioxide production (VCO2) and several ventilatory measures. CPET is increasingly being used as a clinical tool to determine functional capacity, prognosis and potential need for medical or surgical interventions in patients affected by congenital heart disease (CHD). Also in this population, peak VO2 and slope VE/VCO2 are the most predictive parameters in terms of mortality and need of hospitalization. Cyanotic patients with Esisenmenger syndrome show the worst functional limitation and consequently the worst prognosis. This article provides basic and practical information about CPET and focuses on its interpretation in patients with CHD.

Original languageItalian
Pages (from-to)256-259
Number of pages4
JournalPediatria Medica e Chirurgica
Volume32
Issue number6
Publication statusPublished - Nov 2010

Fingerprint

Exercise Test
Heart Diseases
Exercise
Respiratory Muscles
Carbon Dioxide
Hospitalization
Gases
Oxygen
Mortality
Population

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Surgery

Cite this

Prova cardiopolmonare in pazienti adulti con cardiopatia congenita. / Negura, D.; Micheletti, A.; Chessa, M.; Calaciura, R.; Saracino, A.; Butera, G.; Piazza, L.; Arcidiacono, C.; Carminati, M.

In: Pediatria Medica e Chirurgica, Vol. 32, No. 6, 11.2010, p. 256-259.

Research output: Contribution to journalArticle

Negura, D, Micheletti, A, Chessa, M, Calaciura, R, Saracino, A, Butera, G, Piazza, L, Arcidiacono, C & Carminati, M 2010, 'Prova cardiopolmonare in pazienti adulti con cardiopatia congenita.', Pediatria Medica e Chirurgica, vol. 32, no. 6, pp. 256-259.
Negura D, Micheletti A, Chessa M, Calaciura R, Saracino A, Butera G et al. Prova cardiopolmonare in pazienti adulti con cardiopatia congenita. Pediatria Medica e Chirurgica. 2010 Nov;32(6):256-259.
Negura, D. ; Micheletti, A. ; Chessa, M. ; Calaciura, R. ; Saracino, A. ; Butera, G. ; Piazza, L. ; Arcidiacono, C. ; Carminati, M. / Prova cardiopolmonare in pazienti adulti con cardiopatia congenita. In: Pediatria Medica e Chirurgica. 2010 ; Vol. 32, No. 6. pp. 256-259.
@article{88e1c54ad6f646e1a5fa2de88438833d,
title = "Prova cardiopolmonare in pazienti adulti con cardiopatia congenita.",
abstract = "Cardiopulmonary exercise testing (CPET) gives important information about functional capacity by direct measurement of exercise respiratory gas exchange. It provides assessment of the integrative exercise responses involving the cardiovascular, respiratory and muscle-skeletal systems which are not adequately investigated through the measurement of individual organ system function. CPET involves measurements of oxygen uptake (VO2), carbon dioxide production (VCO2) and several ventilatory measures. CPET is increasingly being used as a clinical tool to determine functional capacity, prognosis and potential need for medical or surgical interventions in patients affected by congenital heart disease (CHD). Also in this population, peak VO2 and slope VE/VCO2 are the most predictive parameters in terms of mortality and need of hospitalization. Cyanotic patients with Esisenmenger syndrome show the worst functional limitation and consequently the worst prognosis. This article provides basic and practical information about CPET and focuses on its interpretation in patients with CHD.",
author = "D. Negura and A. Micheletti and M. Chessa and R. Calaciura and A. Saracino and G. Butera and L. Piazza and C. Arcidiacono and M. Carminati",
year = "2010",
month = "11",
language = "Italian",
volume = "32",
pages = "256--259",
journal = "Pediatria Medica e Chirurgica",
issn = "0391-5387",
publisher = "Vicenza Pediatria Medica E Chirurgica",
number = "6",

}

TY - JOUR

T1 - Prova cardiopolmonare in pazienti adulti con cardiopatia congenita.

AU - Negura, D.

AU - Micheletti, A.

AU - Chessa, M.

AU - Calaciura, R.

AU - Saracino, A.

AU - Butera, G.

AU - Piazza, L.

AU - Arcidiacono, C.

AU - Carminati, M.

PY - 2010/11

Y1 - 2010/11

N2 - Cardiopulmonary exercise testing (CPET) gives important information about functional capacity by direct measurement of exercise respiratory gas exchange. It provides assessment of the integrative exercise responses involving the cardiovascular, respiratory and muscle-skeletal systems which are not adequately investigated through the measurement of individual organ system function. CPET involves measurements of oxygen uptake (VO2), carbon dioxide production (VCO2) and several ventilatory measures. CPET is increasingly being used as a clinical tool to determine functional capacity, prognosis and potential need for medical or surgical interventions in patients affected by congenital heart disease (CHD). Also in this population, peak VO2 and slope VE/VCO2 are the most predictive parameters in terms of mortality and need of hospitalization. Cyanotic patients with Esisenmenger syndrome show the worst functional limitation and consequently the worst prognosis. This article provides basic and practical information about CPET and focuses on its interpretation in patients with CHD.

AB - Cardiopulmonary exercise testing (CPET) gives important information about functional capacity by direct measurement of exercise respiratory gas exchange. It provides assessment of the integrative exercise responses involving the cardiovascular, respiratory and muscle-skeletal systems which are not adequately investigated through the measurement of individual organ system function. CPET involves measurements of oxygen uptake (VO2), carbon dioxide production (VCO2) and several ventilatory measures. CPET is increasingly being used as a clinical tool to determine functional capacity, prognosis and potential need for medical or surgical interventions in patients affected by congenital heart disease (CHD). Also in this population, peak VO2 and slope VE/VCO2 are the most predictive parameters in terms of mortality and need of hospitalization. Cyanotic patients with Esisenmenger syndrome show the worst functional limitation and consequently the worst prognosis. This article provides basic and practical information about CPET and focuses on its interpretation in patients with CHD.

UR - http://www.scopus.com/inward/record.url?scp=79957490000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957490000&partnerID=8YFLogxK

M3 - Articolo

C2 - 21462446

AN - SCOPUS:79957490000

VL - 32

SP - 256

EP - 259

JO - Pediatria Medica e Chirurgica

JF - Pediatria Medica e Chirurgica

SN - 0391-5387

IS - 6

ER -